Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1I249/M280-expressing retina
Kaira A. Church(Texas Center for Infectious Disease), Astrid E. Cardona(The University of Texas at San Antonio), Difernando Vanegas(Texas Center for Infectious Disease), Derek Rodriguez(Texas Center for Infectious Disease), Stefka Gyoneva(Biogen (United States)), Richard M. Ransohoff(Cleveland Clinic Lerner College of Medicine), Andrew S. Mendiola(Gladstone Institutes), Tejbeer Kaur(Rutgers, The State University of New Jersey), Priscila Velazquez(The University of Texas at San Antonio), Anne C. Cotleur(Biogen (United States)), Irene L. Gutiérrez(Universidad Complutense de Madrid), Sandra M. Cardona(The University of Texas at San Antonio), Ian M. Tamayo(The University of Texas at San Antonio), Abdul Amadu(The University of Texas at San Antonio)
Cited by 20
Related Papers
The IL-1β phenomena in neuroinflammatory diseases
|Journal of Neural Transmission|2017|301
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
|Nature Immunology|2018|210
Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage
|Neuron|2017|206
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
|Nature Immunology|2020|202
The Role of Microglia in Diabetic Retinopathy
|Journal of Ophthalmology|2014|191